• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Dual Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation: Insights From the Milan Cohort.

作者信息

Mitomo Satoru, Latib Azeem, Tanaka Akihito, Jabbour Richard J, Regazzoli Damiano, Leone Pier Pasquale, Giannini Francesco, Chieffo Alaide, Carlino Mauro, Montorfano Matteo, Colombo Antonio

出版信息

JACC Cardiovasc Interv. 2017 Jul 24;10(14):1471-1472. doi: 10.1016/j.jcin.2017.05.040.

DOI:10.1016/j.jcin.2017.05.040
PMID:28728665
Abstract
摘要

相似文献

1
Dual Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation: Insights From the Milan Cohort.
JACC Cardiovasc Interv. 2017 Jul 24;10(14):1471-1472. doi: 10.1016/j.jcin.2017.05.040.
2
Thirty days only double antiplatelet therapy after drug-eluting stenting: could a 'short-term' treatment be advantageous?药物洗脱支架置入术后仅进行30天双重抗血小板治疗：“短期”治疗是否具有优势？
J Cardiovasc Med (Hagerstown). 2018 Feb;19 Suppl 1:e21-e25. doi: 10.2459/JCM.0000000000000559.
3
Clinical results of single and multiple bioresorbable drug-eluting scaffolds for treatment of de-novo coronary artery disease.单生物可吸收药物洗脱支架和多生物可吸收药物洗脱支架治疗初发冠状动脉疾病的临床结果
Coron Artery Dis. 2016 Nov;27(7):561-5. doi: 10.1097/MCA.0000000000000392.
4
Antiplatelet Therapy After Implantation of Bioresorbable Vascular Scaffolds: A Review of the Published Data, Practical Recommendations, and Future Directions.生物可吸收血管支架置入后抗血小板治疗：文献回顾、实用建议及未来方向
JACC Cardiovasc Interv. 2017 Mar 13;10(5):425-437. doi: 10.1016/j.jcin.2016.12.279.
5
Bioresorbable vascular scaffold fracture in the overlapping zone as cause of accelerated neoatherosclerosis and in-scaffold very-late thrombosis.重叠区域的生物可吸收血管支架断裂是加速新生动脉粥样硬化和支架内极晚期血栓形成的原因。
Int J Cardiovasc Imaging. 2017 Jan;33(1):1-3. doi: 10.1007/s10554-016-0967-0. Epub 2016 Aug 25.
6
Bioresorbable Vascular Scaffolds and Very Late Scaffold Thrombosis: Searching an Explanation and a Solution.生物可吸收血管支架与极晚期支架血栓形成：探寻解释与解决方案
JACC Cardiovasc Interv. 2017 Apr 10;10(7):745-746. doi: 10.1016/j.jcin.2017.01.037.
7
Should all stent patients have prolonged dual antiplatelet therapy?所有支架植入患者都应该接受延长的双联抗血小板治疗吗？
JACC Cardiovasc Interv. 2015 May;8(6):873-875. doi: 10.1016/j.jcin.2015.04.001.
8
Safety and efficacy of 6-month versus 12-month dual antiplatelet therapy in patients after implantation of multiple biodegradable polymer-coated sirolimus-eluting coronary stents: Insight from the I-LOVE-IT 2 trial.6个月与12个月双重抗血小板治疗在多个生物可降解聚合物涂层西罗莫司洗脱冠状动脉支架植入术后患者中的安全性和有效性：来自I-LOVE-IT 2试验的见解。
Catheter Cardiovasc Interv. 2017 Mar;89(S1):555-564. doi: 10.1002/ccd.26947.
9
Bioresorbable scaffolds compared with everolimus-eluting stents for the treatment of chronic coronary total occlusion: clinical and angiographic results of a matched paired comparison.生物可吸收支架与依维莫司洗脱支架治疗慢性冠状动脉完全闭塞的比较：配对比较的临床和血管造影结果
Coron Artery Dis. 2017 Mar;28(2):120-125. doi: 10.1097/MCA.0000000000000449.
10
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry.双联抗血小板治疗停药与糖尿病或非糖尿病患者药物洗脱支架置入术后不良事件风险的相关性、发生率及模式：PARIS 注册研究结果。
JACC Cardiovasc Interv. 2017 Apr 10;10(7):645-654. doi: 10.1016/j.jcin.2016.12.003. Epub 2017 Mar 15.